Cellular Biomedicine Group Inc operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellular Biomedicine Group Inc with three other
companies in this sector in the United States:
Marker Therapeutics Inc(Pre-Reincorporation)
sales of $205,994.00
Sunesis Pharmaceuticals, Inc.
of which 100%
was Small Molecule Therapeutics), and
of which 80%
Cellular Biomedicine Group Inc reported sales of $224,403.00
December of 2018.
decrease of 33.4%
versus 2017, when the company's sales were $336,817.00 .